What is the recommended follow‑up for a 36‑year‑old woman whose initial Pap smear showed low‑grade squamous intraepithelial lesion (LSIL) with negative high‑risk HPV, and whose subsequent Pap smears are normal (negative for intraepithelial lesion) with negative HPV?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Recommended Follow-Up: Return to Routine Screening

For this 36-year-old woman with an initial LSIL/HPV-negative result followed by two consecutive normal Pap tests with negative HPV, she should return to routine age-appropriate screening—either co-testing (Pap + HPV) every 5 years or Pap alone every 3 years.

Clinical Reasoning

This patient's scenario represents a low-risk situation that has resolved. According to the 2019 ASCCP Risk-Based Management Guidelines, the key principle is managing patients based on their current risk for CIN3+, not simply on the presence of an abnormal result 1.

Why This Patient Can Return to Routine Screening

The 2019 guidelines specifically address this exact scenario in their comparison table: when a patient has LSIL with negative HPV preceded by negative screening results within the previous 5 years, the recommendation is to repeat HPV testing (with or without Pap) in 1 year rather than proceeding directly to colposcopy 1.

This patient has now exceeded that requirement with two consecutive normal results (NIL/HPV-negative), which substantially reduces her risk below the clinical action threshold for continued surveillance.

Risk Stratification Evidence

The evidence supporting this approach is robust:

  • Women with HPV-negative LSIL have a very low risk of CIN3+: only 2-4% over 2 years, compared to 13-19% in HPV-positive LSIL 2
  • The negative predictive value of HPV testing for HSIL detection is 99.6% 3
  • After two consecutive negative co-tests, the 5-year risk of CIN3+ is approximately 0.16% 4

Important Caveats

Do not apply this recommendation if:

  • The patient has a history of high-grade lesions (CIN2/3, HSIL, ASC-H, AGC, or AIS) 1
  • The negative HPV tests occurred during surveillance for a previous abnormal result rather than routine screening 1
  • The patient is immunocompromised (e.g., HIV-positive), in which case more frequent screening is warranted 5

Practical Implementation

For this patient at age 36:

  • Preferred: Co-testing (Pap + HPV) every 5 years 6, 4
  • Acceptable alternative: Pap alone every 3 years if co-testing unavailable 6

The two consecutive normal results with negative HPV testing have effectively "reset" her risk to that of the general screening population 1, 4. The initial LSIL was likely a transient HPV infection that has cleared, as occurs in the majority of cases 7.

Related Questions

What are the management guidelines for a cervical Pap showing low‑grade squamous intraepithelial lesion (LSIL) with a negative human papillomavirus (HPV) test?
For a 53-year-old woman with a Pap smear showing low-grade squamous intraepithelial lesion (LSIL) and high-risk human papillomavirus (HPV) E6/E7 positivity, and colposcopic findings of LSIL/cervical intraepithelial neoplasia grade 1 (CIN 1), what is the recommended follow-up?
In a 54-year-old woman with a Pap smear showing low-grade squamous intraepithelial lesion (LSIL) and a negative human papillomavirus (HPV) test, and no known prior cervical abnormalities, what is the appropriate management?
What is the appropriate next step in management for a 34‑year‑old woman with persistent low‑grade squamous intraepithelial lesion (LSIL) and high‑risk HPV‑positive Pap smear after a prior benign colposcopy?
For a 22-year-old female with a Pap (Papanicolaou) test result of LSIL (Low-grade Squamous Intraepithelial Lesion), should HPV (Human Papillomavirus) testing have been automatically reflexed by the lab?
What anatomical structures prevent a hematoma from extending into the anal region when Buck's fascia is torn?
When is it appropriate to use imipramine (tricyclic antidepressant) together with vesicare (solifenacin) for over‑active bladder?
What are the limitations and recommended guidelines for using hydrogen peroxide in wound care?
How should a 3‑ to 4‑month‑old breast‑fed infant with a small amount of blood in the diaper and a history of failure‑to‑thrive (now gaining weight appropriately) be evaluated and managed?
How should a vertebral artery aneurysm be evaluated and managed?
In patients with subarachnoid hemorrhage, what is levetiracetam used for?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.